Booz Allen Hamilton Holding Corporation (BAH) Stock Price Today
Aura AI Summary
Key Stats
- $7.66BMarket Cap
- -Volume
- IndustrialsSector
- $115.9552W High
- $59.7152W Low
- -Typical Hold Time
- $11.05BEnterprise Value
- 3.7%Div Yield
- -Trading Activity
Track Booz Allen Hamilton Holding Corporation (BAH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Booz Allen Hamilton Holding Corporation has traded between a low of $59.71 and a high of $115.95, highlighting its annual price range. Buy and sell Booz Allen Hamilton Holding Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Most Recent News
Grindr stock shows 23.37% growth potential after recent mixed market moves.
Grindr Inc's stock rose 11.04% over the past month but declined 8.81% in the last 10 days, reaching a local low. Despite this recent drop, the stock has a strong growth potential of 23.37%, supported by a robust Piotroski Score of 8, indicating solid...

Global Botulinum Toxin in Urology Market to reach $1.98B by 2035 with 6.08% CAGR, driven by aging population and advanced treatments
The global Botulinum Toxin in Urology Market is projected to grow from approximately USD 1.16 billion in 2026 to USD 1.98 billion by 2035, at a CAGR of 6.08%. Growth is fueled by increasing prevalence of urological disorders like overactive bladder, ...

BioLife Solutions downgraded to Hold amid $1.5B Repligen acquisition and shareholder fairness probe
BioLife Solutions stock was downgraded to a 'Hold' rating with a $31 price target by Lake Street amid its proposed $1.5 billion acquisition by Repligen Corporation. The deal, a cash-and-stock offer, is under legal scrutiny by Halper Sadeh LLC, which ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.